All posts tagged "GILD"
-
FDA Approves First-In-Class HIV Treatment Option
Gilead Sciences, Inc. (Nasdaq: GILD) recently announced that Sunlenca® (lenacapavir), in combination with other antiretroviral(s) (ARV), has been granted approval by the U.S. Food and Drug...
PRIDE & EVENTS
RA News Updates
